Clinical trial
Oxaliplatin in Treating Patients With Metastatic Bladder Cancer
NCT00004203 · University of Chicago, Other · Completed
Key facts
| NCT number | NCT00004203 |
|---|---|
| Title | Oxaliplatin in Treating Patients With Metastatic Bladder Cancer |
| Official title | A Phase II Study of Oxaliplatin in Urothelial Cancer |
| Lead sponsor | University of Chicago, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter |
| Intervention type | Drug |
| Interventions | oxaliplatin |
| Enrollment | 20 |
| Start date | Feb 1, 2000 |
| Primary completion | Feb 1, 2002 |
| Completion | Apr 1, 2005 |
| First posted | Feb 12, 2004 |
| Last update posted | Sep 5, 2013 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: